CD-20 expression in post-transplant lymphoproliferative disorders: Treatment with rituximab

Journal article

Peer reviewed

J. J IFTHIKHARUDDIN, L. A MIELES, J. D ROSENBLATT, C. K RYAN and D. M SAHASRABUDHE

American journal of hematology, Vol.65(2), pp.171-173

2000

PMID: 10996837

Abstract

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

Antineoplastic Agents

Immunotherapy

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.916 Epstein-Barr Virus
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: CD-20 expression in post-transplant lymphoproliferative disorders: Treatment with rituximab
Creators: J. J IFTHIKHARUDDIN - Department of Hematology-Oncology, University of Rochester, Strong Memorial Hospital, Rochester, New York, United States
L. A MIELES - Department of Surgery, Section of Solid Organ Transplantation, University of Rochester, Strong Memorial Hospital, Rochester, New York, United States
J. D ROSENBLATT - Department of Hematology-Oncology, University of Rochester, Strong Memorial Hospital, Rochester, New York, United States
C. K RYAN - Department of Pathology and Laboratory Medicine, University of Rochester, Strong Memorial Hospital, Rochester, New York, United States
D. M SAHASRABUDHE - Department of Hematology-Oncology, University of Rochester, Strong Memorial Hospital, Rochester, New York, United States
Publication Details: American journal of hematology, Vol.65(2), pp.171-173
Publisher: Wiley-Liss; New York, NY
Academic Unit: UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 10996837
Record Identifier: 991031562877402976